Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its... see more

TSXV:SQD.H - Post Discussion

SQI Diagnostics Inc > High Profile Involvement.... time to shine SQI.
View:
Post by FactFinder1994 on Jul 16, 2021 1:26am

High Profile Involvement.... time to shine SQI.

A multi billion dollar opportunity where potentially millions of lives will be touched in the near future given the intellectual properties and technology SQI has developed over the last two decades.  Four FDA shots on goal over the months ahead.    
With all of these high profile people and institutions involved (see below), not to mention tax payer grant money, I think we can expect the Board of Directors to allow for sharing of the story now.  SQI will both directly and indirectly be saving many lives and also be helping so many health care systems in dire need all around the world.  
With over 80% of the float attributed to Insiders, and another 10% held by reputable long holders, it is just a single digit percentage of the float that dictates SQI's current value.  Any awareness at all will create significant pressure on the tiny number of shares available below a dollar, and bring long overdue value integrity.  
 
Dr. Shaf Keshavjee
Sprott Department of Surgery (Lung Transplants)
University Health Network (UHN) Toronto 
(Great work behind the scenes to save lives and bring SQI's diagnostics to the forefront - just scratched the surface here)  
 
Tohid Didar
McMaster University
(Amazing research and development with/for SQI - "smart surface" technology - more to come soon too) 
 
University of Buffalo
(Building data and supporting SQI behind the scenes as well)  
 
US-FDA 
(Working with SQI on EUA process - multiple fronts) 
 
Health Canada 
(Working with SQI) status unknown
 
Clive Beddoe 
Wilmot Matthews 
Gerald Connor 
(The Big Three High Profile Directors of SQI, who have quietly went from owning a quarter of the company collectively, to owning a quarter of the company EACH)
 
 
Eric Brouwer - SQI CSO & Former interim CEO 
Claude Ricks - Former SQI CEO 
Andrew Morris - Former SQI CEO 
(All current Directors that sat in the CEO chair at SQI, who all continue to be very much involved)
 
Eric Zwisler - SQI Director, & Chairman of the La Jolla Institute for Immunology 
(Another incredibly successful individual with global reach)
 
Dr. Peter Lea
(Founder of SQI, and dedicated professional that remains very involved)  
 
Eden Rahim 
Next Edge Capital 
(Supportive Participant in SQI for several years and recently gave them his praise in a small online presentation)
 
Natural Sciences and Engineering Research Council of Canada
(Provided public funding - Canadian Government) 
 
Canadian Institutes of Health Research (CIHR)
(Provided public funding - Canadian Government) 
 
Imaware Health - Jani Tuomi 
(Direct to Consumer Partner of SQI) 
Dr. Eleftherious Diamandis - Medical Biochemistry Professor, & Medical advisor at Imaware (who was one of the individuals that helped debunk/expose Theranos false claims)
Imaware has validated/endorse SQI's technology
 
Azova 
Cheryl Lee Eberting, M.D., CEO & Founder of Azova 
(Distribution partner to SQI for Covid-19 Antibody Test) 
 
All of the above affiliations very much appreciate the impact SQI will make to the lives of so many around the globe.     
 
SQI remains grossly undervalued, however value integrity can correct itself very swiftly when knowledge is shared and this  could become a  with the addition of an IR partner or two, a few Analysts, and a supportive marketing campaign.  
 
Stay tuned, as the world awaits the SQI Story  
Comment by Revten on Jul 16, 2021 7:25am
Gee wissss... does anyone have shares available at 12 Cents? I will take all you have!!... THIS IS GAME CHANGING NEWS FELLOW PATIENT HOLDERS! Pay Day Is On The Way! So Glad I Bought more over the last 2 Weeks! Rev-ed Up
Comment by Muddyork on Jul 23, 2021 8:49pm
Can't imagine Azova being very happy about this...the deal was based on FDA approval Womp wooooomp
Comment by ResearchGuy on Jul 23, 2021 10:06pm
Muddy if I am not mistaken the Azova agreement is regarding the Home Antibody Technology and not with the Triage Technology and if you read the announcement Clive said that the FDA is looking positive in the submission the Home Antibogy EUA application.  Someone correct me if I am wrong !!!!!
Comment by cleareye on Jul 24, 2021 1:16am
I belive you're right ResearchGuy, The EUA application is still ongoing for the Home Antibody test. I think that it must be valid and moving forward if Azova signed the agreement that was announced 8 days ago. I highlighted the announcement this afternoon to make sure it was thrashed out this weekend so investors who reference this board can inform themselves before Monday morning. For some ...more  
Comment by mercedesman on Jul 24, 2021 9:20am
Thx Cleareye  I agree totally.  while the Rali-DX is likely a short term timeline set-back, the big opportunity ( antibody testing) is still in play ... Re: the Anti-body Home-test. The new partner will not treat it simply as a Home test but will offer it through their network of corporate and other clients.  this is the big opportunity. The $3B one ! unfortunately the ...more  
Comment by Muddyork on Jul 24, 2021 10:39am
Thank you Could be rough waters ahead but again an opportunity to add and hold.
Comment by ResearchGuy on Jul 24, 2021 3:46pm
Agreed and yes it will be a good opurtunity to add to your position. Also it's not that the FDA rejected the Triage technology or the clinical results just the review for the EUA application. According to the PR SQI is still encouraged to submit to the FDA but through the normal application process. Yes it will take longer than we all were hoping for but it's not like it's dead in the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities